Navigation Links
BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
Date:2/17/2011

RALEIGH, N.C., Feb. 17, 2011 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today that enrollment of its Phase 3 trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain is on schedule, with over half of the needed subjects enrolled.  

(Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO)

"We are very pleased with the enrollment to date for this pivotal Phase 3 study for our next product BEMA Buprenorphine," stated Dr. Andrew Finn, Executive Vice President of Product Development at BDSI.  "We are on schedule with enrollment as a result of a very focused effort both internally and with the enthusiastic support of an outstanding group of experienced investigators.  Based on current progress, we feel comfortable that we will meet our goal of reporting top-line results in the third quarter of this year.  Positive findings from this study would then allow for an anticipated NDA filing early in the second quarter of 2012."

BDSI believes that there remains a significant unmet medical need for potent new analgesics for the treatment of chronic pain.  Buprenorphine is an attractive option for development because of its potent analgesic properties, its differentiating characteristics from other opioids, and its DEA Schedule III designation, which means there is less addiction potential than Schedule II products.  According to Wolters Kluwer, opioid analgesic sales in the U.S. are in excess of $10 billion and growing, and BDSI believes that BEMA Buprenorphine has the potential to exceed $500 million in peak annual sales.

About BioDelivery Sciences International

BioDelivery Sciences International (Nasdaq: BDSI) is a specialty pharmaceutical co
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
2. Sanofi-aventis and Sunnybrook Health Sciences Centre Agree to Develop Treatment for Diabetic Foot Ulcers
3. Medical Devices and Diagnostics Analyst Joins MLV to Further Expand its Coverage of the Life Sciences Sector
4. OXIS International to Present at the Lippert/Heilshorn Life Sciences and Medtech Virtual Conference on February 17
5. Caliper Life Sciences Fourth Quarter and Fiscal Year 2010 Financial Results Conference Call Notice
6. 3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer
7. Caliper Life Sciences IVIS® Optical Imaging System Adoption Surpasses 1000 Units: Validated Drug Research, Discovery and Development Tool Enables Advances in Personalized Medicine
8. Sangamo BioSciences Announces Presentation at the 13th Annual BIO CEO & Investor Conference
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results
10. Caliper Life Sciences Announces Availability of Automated TruSeq™ Next Generation Sequencing Protocols
11. DARA BioSciences to Present Live at RetailInvestorConferences.com on February 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... initiated a phase I clinical trial in patients ... safety, tolerability, and immunogenicity of INO-3106. This immunotherapy ... most aerodigestive cancers. Aerodigestive cancers affect ... and parts of the esophagus and windpipe. The ...
(Date:9/22/2014)...  CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical ... for the prevention and treatment of cardiorenal and ... TUV-SUD and The Medicinal Evaluation Board of ... its request for a label expansion for Neutrolin, ... in July 2013 for use in the prevention ...
(Date:9/22/2014)... 2014  Seres Health, a clinical-stage therapeutics company developing ... today announced that it has been named by ... companies, designating it as one of the most promising ... "Amid a great deal of ain,t-it-cool science in microbiomics, ... to practical therapeutic development," says Damian Garde , ...
Breaking Medicine Technology:Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Seres Health Named a "Fierce 15" Biotech Company for 2014 2
... BALTIMORE, Feb. 4, 2011 Ameritox®, the nation,s ... to advance its industry leadership position by strengthening ... the past twelve months.  Through significant investments in ... capabilities, Ameritox has reached several milestones – including ...
... R.I., Feb. 4, 2011 MEDfx Corporation today announced ... among providers using a combination of the standards and ... CONNECT Gateway. MEDfx is participating in, and is a ... of the National Coordinator of Health IT.  The MEDfx ...
Cached Medicine Technology:Ameritox® Continues to Advance Industry Leadership 2Ameritox® Continues to Advance Industry Leadership 3Ameritox® Continues to Advance Industry Leadership 4MEDfx to Harmonize the Direct Project With CONNECT 2MEDfx to Harmonize the Direct Project With CONNECT 3
(Date:9/22/2014)... a very familiar "lub-dub" pattern that speeds up or ... pattern itself isn,t as regular as you might think. ... vary even at a "constant" heart rateand that variability, ... Reduced heart rate variability (HRV) has been found to ... congestive heart failure and inflammation. For athletes, a drop ...
(Date:9/22/2014)... 22, 2014 WHO: LiveOps, Inc., ... customer service solutions. , WHAT: The 10th annual ... customer care for the connected consumer. Constant change ... offer new challenges and opportunities for customer experience ... identify best practices, network and learn from fellow ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. ... child,s brain processes sounds might help identify the severity ... Observing children,s brainwaves may also allow identification of autism ... "The finding that the brain,s response to certain ... hugely promising," said senior researcher Sophie Molholm, an associate ...
(Date:9/22/2014)... CA (PRWEB) September 22, 2014 ... California for a three-day conference to discuss brain-related ... brain injury from concussions and neurodegenerative disorders. ... medical director affiliated with a Silverado memory care ... of dedicated expertise in memory care, hosts the ...
(Date:9/22/2014)... The report segments the global physiotherapy ... geography. The equipment segment accounted for a lion’s ... product. However, the accessories segment is expected to ... period, owing to the rising demand of physiotherapy ... segments are the fastest-growing segments in the physiotherapy ...
Breaking Medicine News(10 mins):Health News:Variability keeps the body in balance 2Health News:Variability keeps the body in balance 3Health News:Variability keeps the body in balance 4Health News:LiveOps To Lead Panel Discussion At Customer Response Summit Memphis 2Health News:Brainwaves May Help Gauge Autism Severity: Study 2Health News:Brainwaves May Help Gauge Autism Severity: Study 3Health News:Brainwaves May Help Gauge Autism Severity: Study 4Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 5
... 4 BasicPlus Health,Insurance of Roswell, Ga., announced ... Companion Global Healthcare Inc. of Columbia, S.C., to,include ... most popular,limited benefit health insurance plans., The ... and BasicPlus (for individuals) limited benefit plans have ...
... outlines major issues and best practices for handling fresh, produce that every ... ... to know., ATLANTA, June 4 Fresh produce safety ... public awareness and,industry concern. At its biennial meeting in San Antonio, Texas, ...
... American Society for Investigative Pathology (ASIP) is pleased ... Professor of Pathology and Microbiology-Immunology at Northwestern University ... Amgen Outstanding Investigative Award, a prestigious annual award ... Amgen. Dr. Engman presented his paper, "Pathogenesis ...
... used chlorinated pesticides on more than 100 days in ... to researchers from the National Institutes of Health (NIH). ... from a 20 percent to a 200 percent increase ... Institute of Environmental Health Sciences (NIEHS) and the National ...
... LARGO, Fla., June 4 Unilens Vision ... UVI), which develops,licenses, manufactures, distributes and markets ... program for all Unilens GP (Gas Permeable),products., ... Professional,s Specialty Contact Lens,Company", continues its tradition ...
... 4th International Forum on Disability Management Will be Held in Berlin ... from 22 ... employees,capacity for work following sickness and disablement? Experts from,throughout the world will ... is to be held at the Berlin,Congress Centre from 22 to 24 ...
Cached Medicine News:Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 2Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 3Health News:Chemstar Corporation Publishes New Insights on Fresh Produce Safety From CFP Workshop 2Health News:Long-term pesticide exposure may increase risk of diabetes 2Health News:Long-term pesticide exposure may increase risk of diabetes 3Health News:Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability 2Health News:Retaining Employees' Capacity For Work Following Sickness 2
... a leading provider of immunofluorescence assays, with ... that includes kits for autoimmune diseases, infectious ... conjugates and components. Our Impact IFA Test ... substrates and kit sizes to choose from. ...
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
... Inverness Medical Professional Diagnostics is a leading ... IFA and DFA test menu that includes ... STDs as well as miscellaneous conjugates and ... you a wide assortment of substrates and ...
... is a leading provider of immunofluorescence assays, ... menu that includes kits for autoimmune diseases, ... miscellaneous conjugates and components. Our Impact IFA ... of substrates and kit sizes to choose ...
Medicine Products: